Neuronal Degeneration in Parkinson's Disease

Clinical Presentation

The American College of Radiology suggests that patients with Parkinson's disease typically present with cardinal features, including resting tremor, rigidity, and bradykinesia, which are evident in this patient's symptoms 1
The patient's symptoms, such as resting tremor, rigidity, and bradykinesia, are consistent with the clinical presentation of Parkinson's disease, as described by the American College of Radiology 1, 2

The American College of Radiology states that Parkinson's disease is characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta projecting to the striatum, leading to the manifestation of symptoms after approximately 40-50% of dopaminergic neurons have been lost 1
The disease process involves deposition of Lewy bodies, initially in the medulla oblongata, pontine tegmentum, and olfactory system, with later involvement of the substantia nigra, as described by the American College of Radiology 1

The American College of Radiology notes that while the caudate and putamen are affected in Parkinson's disease, they are the target structures that receive projections from the substantia nigra rather than the primary site of neuronal degeneration 1
Frontotemporal lobe degeneration is associated with frontotemporal dementia rather than classic parkinsonian symptoms, according to the American College of Radiology 3

The patient's history of hypertension and previous ischemic stroke are risk factors for vascular parkinsonism, but his presentation with asymmetric resting tremor is more consistent with idiopathic Parkinson's disease, as suggested by the American College of Radiology 1
The peak age of onset for PD is between 60-70 years, consistent with this patient's presentation, according to Praxis Medical Insights 2

The American College of Radiology recommends that MRI of the brain without contrast is the optimal imaging modality for evaluating patients with parkinsonian syndromes, though it may be normal in early PD 1
Advanced imaging techniques like FDG-PET may demonstrate early neostriatal dysfunction in PD, which can precede detectable neuronal loss on structural imaging, as described by the American College of Radiology 1